-
-
-
-
-
-
-
FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
-
-
-
-
-
-
-
Paratek's (PRTK) NDA for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA
-
-
-
-
15,418 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

